Escalating dosing regimen for effecting weight loss and treating obesity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 12, 2013
Grant Date -
Dec 10, 2009
app pub date -
Jun 9, 2009
filing date -
Jun 9, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is drawn to novel topiramate compositions as well as methods for effecting weight loss, e.g., in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se. The present invention features an escalating dosing regimen adapted for the administration of topiramate and optionally a sympathomimetic agent such as phentermine or bupropion, in the treatment of obesity and related conditions.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully